Literature DB >> 20629137

A retrospective study of the impact of lifestyle on age at onset of Huntington disease.

M Kaye Trembath1, Zoë A Horton, Lynette Tippett, Virginia Hogg, Veronica R Collins, Andrew Churchyard, Dennis Velakoulis, Richard Roxburgh, Martin B Delatycki.   

Abstract

In transgenic mouse models of Huntington disease (HD) environmental enrichment significantly delays disease onset. A questionnaire-based survey of 154 adults with diagnosed HD (mean 4.2 years postdiagnosis) and a known IT15 CAG repeat length, explored whether premorbid lifestyle may relate to age-at-onset (AO). Participants were drawn from HD outpatient clinics in Australia and New Zealand. Premorbid physical, intellectual, and passive activity levels were used to generate scores in the categories of leisure, nonleisure (education, occupation and domestic duties) and total lifestyle. AO was associated with increased CAG repeat length as expected (r = -0.72, P < 0.001), but also with a lifestyle that included higher levels of passive activity (r = -0.38, P < 0.001). Multiple linear regression modeling showed lifestyle passivity to be a variable independent of CAG repeat length in predicting AO (R(2) = 0.54, b = -0.22, P = 0.005). Comparison of the mean AO across tertiles of lifestyle passivity scores showed onset 4.6 years (95% CI = 1.3-7.9) later in the least compared with the most passive tertile. CAG repeat length was also shown to predict lifestyle passivity (R(2) = 0.12, b = 1.08, P < 0.0005). Neither intellectual nor physical activity showed significant relationships to AO or CAG repeat length in this cohort. Our study leads to two conclusions: that a passive lifestyle may be a preclinical expression of HD, and that it actually contributes to the earlier onset of symptoms. Overcoming the tendency to be passive may substantially delay onset of HD. (c) 2010 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20629137     DOI: 10.1002/mds.23108

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  27 in total

Review 1.  From Disease to Health: Physical Therapy Health Promotion Practices for Secondary Prevention in Adult and Pediatric Neurologic Populations.

Authors:  Lori Quinn; Don Morgan
Journal:  J Neurol Phys Ther       Date:  2017-07       Impact factor: 3.649

2.  Quantifying the bias due to observed individual confounders in causal treatment effect estimates.

Authors:  Layla Parast; Beth Ann Griffin
Journal:  Stat Med       Date:  2020-05-10       Impact factor: 2.373

3.  Clinical and genetic data of Huntington disease in Moroccan patients.

Authors:  Ahmed Bouhouche; Wafaa Regragui; Hind Lamghari; Khadija Khaldi; Nazha Birouk; Safaa Lytim; Soufiane Bellamine; Yamna Kriouile; Naima Bouslam; El Hachmia Ait Ben Haddou; Mustapha Alaoui Faris; Ali Benomar; Mohamed Yahyaoui
Journal:  Afr Health Sci       Date:  2015-12       Impact factor: 0.927

4.  Differential effects of early environmental enrichment on emotionality related behaviours in Huntington's disease transgenic mice.

Authors:  Thibault Renoir; Terence Y C Pang; Christina Mo; Grace Chan; Caroline Chevarin; Laurence Lanfumey; Anthony J Hannan
Journal:  J Physiol       Date:  2012-10-08       Impact factor: 5.182

Review 5.  DNA methylation in Huntington's disease: Implications for transgenerational effects.

Authors:  Elizabeth A Thomas
Journal:  Neurosci Lett       Date:  2015-11-11       Impact factor: 3.046

Review 6.  Understanding the Outcomes Measures used in Huntington Disease Pharmacological Trials: A Systematic Review.

Authors:  Noelle E Carlozzi; Angela Miciura; Nicholas Migliore; Praveen Dayalu
Journal:  J Huntingtons Dis       Date:  2014

Review 7.  Statistical modeling of Huntington disease onset.

Authors:  Tanya P Garcia; Karen Marder; Yuanjia Wang
Journal:  Handb Clin Neurol       Date:  2017

8.  The Effect of Education on Symptom Onset and Severity of Huntington's Disease.

Authors:  Kristina K Cain; Joseph L Flanigan; William Alex Dalrymple; James Patrie; Madaline B Harrison; Matthew J Barrett
Journal:  Mov Disord Clin Pract       Date:  2021-03-30

9.  Estimating the causal effects of modifiable, non-genetic factors on Huntington disease progression using propensity score weighting.

Authors:  Beth Ann Griffin; Marika Suttorp Booth; Monica Busse; Edward J Wild; Claude Setodji; John H Warner; Cristina Sampaio; Amrita Mohan
Journal:  Parkinsonism Relat Disord       Date:  2021-01-13       Impact factor: 4.891

10.  Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington's disease: zQ175.

Authors:  Liliana B Menalled; Andrea E Kudwa; Sam Miller; Jon Fitzpatrick; Judy Watson-Johnson; Nicole Keating; Melinda Ruiz; Richard Mushlin; William Alosio; Kristi McConnell; David Connor; Carol Murphy; Steve Oakeshott; Mei Kwan; Jose Beltran; Afshin Ghavami; Dani Brunner; Larry C Park; Sylvie Ramboz; David Howland
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.